Product
LY3561774
1 clinical trial
4 indications
Indication
DyslipidemiaIndication
Lipid Metabolism DisordersIndication
Metabolic DiseasesIndication
HyperlipoproteinemiaClinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 in Adults With Mixed DyslipidemiaStatus: Active (not recruiting), Estimated PCD: 2024-03-04